NBD-557(333352-59-3)
- Name: NBD-557
- Synonyms:NBD-557;N-(4-Bromophenyl)-N'-(2,2,6,6-tetramethylpiperidin-4-yl)oxalamide
- Molecular Formula:C17H24BrN3O2
- Molecular Weight:382.29536
- CAS Registry Number:333352-59-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.333352-59-3 NBD-557
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.333352-59-3 NBD-557
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:NBD-557
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.333352-59-3 NBD-557
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] CAS No.333352-59-3 NBD-557
Assay:>98% Package:inquiry Transportation:inquiry Application:NBD-557 is a N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamide analog, a novel class of human immunodeficiency virus type 1 (HIV-1) entry inhibitors that block the gp120-CD4 interaction,
Min. Order:0
Supplier:BOC Sciences [
United States] CAS No.333352-59-3 NBD-557
Assay:98% Package:According to the demand of customer Storage:Sealed, dry, microtherm , avoid light and smell. Transportation:by air or by sea Application:Organic synthesis
Min. Order:0
Supplier:Henan Allgreen Chemical Co.,Ltd [
China (Mainland)]
Other Product
- 1269815-17-9/Piperidine-3-carboxylic acid [5-chloro-4-(5-fluoro-2-methoxy-phenyl)-pyridin-2-yl]-amide
- 1218779-75-9/N-[4-(1-Cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide methanesulfonate
- 445493-23-2/11107B
- 1177489-18-7/CASPASE-13 INHIBITOR I
- 1142214-62-7/AM-1638
- 4727-31-5/Kartogenin
- 195883-07-9/YM 273
- 865784-01-6/ON 013105
- 857070-65-6/1-((3-hydroxy-6-Methylpyridin-2-yl)Methyl)-2-((3-Morpholinopropyl)aMino)-1H-benzo[d]iMidazole-6-carbaldehyde
- 857067-38-0/2-((6-(hydroxyMethyl)-2-((3-Morpholinopropyl)aMino)-1H-benzo[d]iMidazol-1-yl)Methyl)-6-Methylpyridin-3-ol
- 245414-50-0/3-(((2R,3R)-4-((3S,4aS,8aS)-3-(tert-butylcarbaMoyl)octahydroisoquinolin-2(1H)-yl)-3-hydroxy-1-(phenylthio)butan-2-yl)carbaMoyl)-2-Methylphenyl acetate
- 857071-75-1/(E)-3-(4-Methyl-2-nitrophenyl)prop-2-en-1-ol
- 662151-10-2/ML-220
- 1354792-97-4/NI-07
- 1005780-62-0/TAK-593
- 926291-77-2/Benzeneethanol, β-aMino-3-chloro-, (βR)-
- 1286739-19-2/6-(2-Chloro-4-thiazol-5-yl-phenyl)-8-ethyl-2-[4-(4-Methyl-piperazin-1-yl)-phenylaMino]-8H-pyrido[2,3-d]pyriMidin-7-one
- 131918-62-2/19-nor-Doxercalciferol
- 1260907-17-2/GSK 525762A
- 333352-59-3/NBD-557
- 1096708-71-2/6-Amino-5-chloro-N-[(1R)-1-[5-[[[5-chloro-4-(trifluoromethyl)-2-pyridinyl]amino]carbonyl]-2-thiazolyl]ethyl]-4-pyrimidinecarboxamide
- 914462-92-3/Rolapitant hydrochloride
- 916151-99-0/LOR 253
- 929721-98-2/Impurity A of Maxacalcitol
- 1217835-38-5/(R)-(2,3-dimethyl-3-((trimethylsilyl)oxy)butyl)diphenylphosphine oxide
- 87407-51-0/(S)-2-((1R,3aS,7aR,E)-4-((E)-2-((S)-5-((tert-butyldiMethylsilyl)oxy)-2-Methylenecyclohexylidene)ethylidene)-7a-Methyloctahydro-1H-inden-1-yl)propan-1-ol
- 112875-61-3/(1S,4R,E)-4-((1R,3aS,7aR,E)-4-((Z)-2-((3S,5R)-3,5-bis((tert-butyldiMethylsilyl)oxy)-2-Methylenecyclohexylidene)ethylidene)-7a-Methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol
- 333353-44-9/NBD-556
- 81506-24-3/(Z)-2-((3S,5R)-3,5-bis((tert-butyldiMethylsilyl)oxy)-2-Methylenecyclohexylidene)ethanol
- 1431612-23-5/UNC 1999